Literature DB >> 12754523

Expression profiling reveals off-target gene regulation by RNAi.

Aimee L Jackson1, Steven R Bartz, Janell Schelter, Sumire V Kobayashi, Julja Burchard, Mao Mao, Bin Li, Guy Cavet, Peter S Linsley.   

Abstract

RNA interference is thought to require near-identity between the small interfering RNA (siRNA) and its cognate mRNA. Here, we used gene expression profiling to characterize the specificity of gene silencing by siRNAs in cultured human cells. Transcript profiles revealed siRNA-specific rather than target-specific signatures, including direct silencing of nontargeted genes containing as few as eleven contiguous nucleotides of identity to the siRNA. These results demonstrate that siRNAs may cross-react with targets of limited sequence similarity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12754523     DOI: 10.1038/nbt831

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  773 in total

1.  siRNA-mediated down-regulation of P-glycoprotein in a Xenograft tumor model in NOD-SCID mice.

Authors:  Meysam Abbasi; Hamidreza Montazeri Aliabadi; Elaine H Moase; Afsaneh Lavasanifar; Kamaljit Kaur; Raymond Lai; Charles Doillon; Hasan Uludağ
Journal:  Pharm Res       Date:  2011-06-03       Impact factor: 4.200

2.  Vectors and parameters that enhance the efficacy of RNAi-mediated gene disruption in transgenic Drosophila.

Authors:  Benjamin Haley; Bryon Foys; Michael Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-04       Impact factor: 11.205

3.  Nucleotide sequence homology requirements of HIV-1-specific short hairpin RNA.

Authors:  Oliver Pusch; Daniel Boden; Rebecca Silbermann; Fred Lee; Lynne Tucker; Bharat Ramratnam
Journal:  Nucleic Acids Res       Date:  2003-11-15       Impact factor: 16.971

4.  Inhibition of synapse assembly in mammalian muscle in vivo by RNA interference.

Authors:  Xian Chu Kong; Patrizia Barzaghi; Markus A Ruegg
Journal:  EMBO Rep       Date:  2004-01-16       Impact factor: 8.807

5.  A library of siRNA duplexes targeting the phosphoinositide 3-kinase pathway: determinants of gene silencing for use in cell-based screens.

Authors:  Andrew C Hsieh; Ronghai Bo; Judith Manola; Francisca Vazquez; Olivia Bare; Anastasia Khvorova; Stephen Scaringe; William R Sellers
Journal:  Nucleic Acids Res       Date:  2004-02-09       Impact factor: 16.971

6.  Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs).

Authors:  Stephan P Persengiev; Xiaochun Zhu; Michael R Green
Journal:  RNA       Date:  2004-01       Impact factor: 4.942

7.  Amelioration of colorectal cancer using negative lipidoid nanoparticles to encapsulate siRNA against APRIL by enema delivery mode.

Authors:  Weifeng Ding; Guihua Wang; Keke Shao; Feng Wang; Hua Huang; Shaoqing Ju; Hui Cong; Huimin Wang
Journal:  Pathol Oncol Res       Date:  2014-04-26       Impact factor: 3.201

8.  T cell chemotaxis to lysophosphatidylcholine through the G2A receptor.

Authors:  Caius G Radu; Li V Yang; Mireille Riedinger; Matthew Au; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-17       Impact factor: 11.205

9.  Human mitochondrial peptide deformylase, a new anticancer target of actinonin-based antibiotics.

Authors:  Mona D Lee; Yuhong She; Michael J Soskis; Christopher P Borella; Jeffrey R Gardner; Paula A Hayes; Benzon M Dy; Mark L Heaney; Mark R Philips; William G Bornmann; Francis M Sirotnak; David A Scheinberg
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

10.  Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors.

Authors:  Silvana Konermann; Peter Lotfy; Nicholas J Brideau; Jennifer Oki; Maxim N Shokhirev; Patrick D Hsu
Journal:  Cell       Date:  2018-03-15       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.